Option Care Health, Inc. (OPCH) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001014739 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $1.35B | $45.3M | $0.29 | Filing |
| Dec 31, 2025 | Jan 12, 2026 | — | $58.5M | $0.36 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $1.44B | $51.8M | $0.32 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $1.42B | $50.5M | $0.31 | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $1.33B | $46.7M | $0.28 | Filing |
| Dec 31, 2024 | Jan 13, 2025 | $1.35B | $60.1M | $0.36 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $1.28B | $53.9M | $0.31 | Filing |
| Jun 30, 2024 | Jul 31, 2024 | $1.23B | $53.0M | $0.30 | Filing |
What would Option Care Health, Inc. have to report for its valuation to change?
At $31.20, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 15.8% a year, to $2.67. On that path the next quarter needs diluted EPS near $0.36, against $0.31 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 15.8% | 15.8% |
| EPS needed in final year | $2.67 | $2.67 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. OPCH goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.